Navigating A Pathway to Improve Tretement of Psoriasis

Navigating A Pathway to Improve Tretement of Psoriasis is organized by Annenberg Center for Health Sciences At Eisenhower.

Target Audience:
The target learning audience is a national audience of dermatologists, dermatology physician assistants, nurse practitioners, and other clinicians who treat patients with moderate-to-severe psoriasis.

Available Credit:
• 1.00 AMA PRA Category 1 Credit™.

Content Areas:
• Comorbidities in patients with psoriasis
• Biologic treatments for psoriasis
• Safety of biologic treatments for psoriasis
• TNF-α inhibitors
• IL-17 inhibitors
• IL-23 inhibitors

Additional details will be posted as soon as information is available.